Optimal Timing for Progesterone Administration
For hormone replacement therapy, progesterone should be taken at bedtime (evening dosing) to minimize side effects, particularly drowsiness and dizziness caused by progesterone metabolites. 1, 2
Timing Based on Clinical Indication
Hormone Replacement Therapy (HRT) in Postmenopausal Women
Evening administration is strongly preferred:
- Oral micronized progesterone 200 mg should be taken at bedtime to minimize the sedative effects of 5-alpha-reduced metabolites that can cause drowsiness and impair motor vehicle operation 2
- The FDA-approved regimen for endometrial protection uses 200 mg daily for 12 days per 28-day cycle in combination with conjugated estrogens, with evening dosing recommended 3
- Peak plasma concentrations occur approximately 2 hours after ingestion, making bedtime dosing ideal for sleeping through peak metabolite effects 4
Sequential Regimens for Premature Ovarian Insufficiency
For cyclical administration:
- Oral micronized progesterone (MP) 200 mg daily should be administered for 12-14 days every 28 days when combined with continuous estrogen 1
- Vaginal progesterone 200 mg daily can be given for 12-14 days every 28 days as an alternative route 1
- MP is the first-choice progestin due to lower cardiovascular and thromboembolism risk compared to synthetic progestins 1
Continuous Combined Regimens
For women desiring amenorrhea:
- Oral progesterone 100 mg daily taken continuously (25 days per month) can maintain amenorrhea 2
- Continuous combined patches with 17β-estradiol and progestin can be administered without interruptions 1
Preterm Birth Prevention
Timing varies by indication:
- For women with prior spontaneous preterm birth: 17-alpha-hydroxyprogesterone caproate (17P) 250 mg IM weekly starting at 16-20 weeks until 36 weeks gestation 1, 5
- For women with short cervical length (≤20 mm): vaginal progesterone 90-mg gel or 200-mg suppository daily from diagnosis (18-24 weeks) until 36 weeks 1, 5
- Vaginal progesterone 100 mg nightly from 24-34 weeks has demonstrated efficacy in reducing preterm birth 1
Route-Specific Timing Considerations
Oral Administration
- Twice-daily dosing (100 mg morning, 200 mg evening) maintains more sustained progesterone and metabolite levels over 24 hours compared to once-daily dosing 4
- However, single evening dosing of 200-300 mg is preferred for compliance and side effect management 2
- The 300 mg dose taken at bedtime is commonly used in Europe for endometrial protection 2
Vaginal Administration
- Vaginal progesterone can be administered once daily at any time due to direct uterine uptake via first-uterine-pass effect, which produces adequate endometrial effects despite lower systemic levels 6
- The bioadhesive gel formulation provides controlled, sustained release regardless of timing 6
Intramuscular Administration
- 17P injections are given weekly on the same day each week, with timing during the day being less critical than consistency 1
Critical Pitfalls to Avoid
- Do not administer oral progesterone in the morning if sedation is a concern, as peak metabolite levels coincide with daytime activities and can impair function 2
- Do not use synthetic progestins (medroxyprogesterone acetate, norethindrone) when natural progesterone is available, as they cause more metabolic, vascular, and psychological side effects 6, 2
- Do not start progestin before adequate endometrial development in pubertal induction—wait 2-3 years after estrogen initiation or until breakthrough bleeding occurs 1
- Do not confuse timing recommendations for different indications: preterm birth prevention requires different schedules than HRT 1, 5